Traws Pharma, Inc. 8-K Filing: Key Updates for Investors - Feb 2025

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

Company Identification:

Company Name: Traws Pharma, Inc.
CIK Number: 0001130598
State of Incorporation: Delaware (DE)
SEC File Number: 001-36020
Tax Identification Number: 22-3627252

Document Type and Date:

Filing Type: 8-K
Date of Filing: February 17, 2025

Address and Contact Information:

Address: 12 Penns Trail, Newtown, PA 18940
Phone Number: 267-759-3680

Stock Information:

Common Stock Par Value: $0.01 per share
Ticker Symbol: TRAW
Exchange: NASDAQ

Reporting Context:

Reporting Date: The report is as of February 17, 2025.
Measurement Units:
- Financial amounts are reported in US Dollars (USD).
- Shares are used as a unit of measurement for stock-related disclosures.

Insights:

Traws Pharma, Inc. appears to be a publicly traded company listed on NASDAQ under the ticker symbol TRAW.
The filing of an 8-K indicates that this report may contain significant updates or events that are material to the shareholders or investors, which could relate to corporate governance, financial performance, or other significant corporate events.
The specific date of the report suggests that the company is providing timely information to comply with SEC regulations.
The par value of the common stock indicates that the company's equity structure allows for shares with a nominal value, which is typical in corporate finance.

This information is critical for stakeholders, including investors, analysts, and regulators, to assess the company’s financial status and operational updates.